bioAffinity Technologies to present CyPath Lung data at NAVREF 2026
The company said it will present two posters on clinical and veteran-focused data for its noninvasive CyPath Lung test at NAVREF 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
bioAffinity to present CyPath Lung data at NAVREF 2026 conference
bioAffinity Technologies says it will present two posters on its noninvasive lung cancer diagnostic CyPath® Lung at the NAVREF 2026 Annual Conference.